Viruses in chronic progressive neurologic disease

Multiple Sclerosis

Volumn 24, Issue 1, 2018, Pages 48-52

  Leibovitch, Emily C ^a   Jacobson, Steven ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

central nervous system inflammation; herpesviruses; Human herpesvirus 6 (HHV 6); multiple sclerosis; viral triggers

Indexed keywords

ARTICLE; CALLITRICHINAE; DISEASE ASSOCIATION; DISEASE MODEL; EPSTEIN BARR VIRUS; HUMAN; HUMAN HERPESVIRUS 6; INOCULATION; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PATHOGENESIS; PRIMATE;

EID: 85040353075     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458517737392     Document Type: Article

References (29)

1. Venkatesan A, Johnson RT., Infections and multiple sclerosis. In: Goodin DS, (ed.) Handbook of clinical neurology. Amsterdam: Elsevier B.V., 2014; 151–171.
2. Virtanen JO, Wohler J, Fenton K. Oligoclonal bands in multiple sclerosis reactive against two herpesviruses and association with magnetic resonance imaging findings. Mult Scler 2014; 20(1): 27–34.
3. Gilden DH., Viruses and multiple sclerosis. JAMA 2001; 286(24): 3127–3129.
4. Harberts E, Yao K, Wohler J. Human herpesvirus-6 entry into the central nervous system through the olfactory pathway. PNAS 2011; 108(33): 13734–13739.
5. Zerr DM, Meier AS, Selke SS. A population-based study of primary human herpesvirus 6 infection. N Engl J Med 2005; 352(8): 768–776.
6. Tesini BL, Epstein LG, Caserta MT., Clinical impact of primary infection with roseoloviruses. Curr Opin Virol 2014; 9: 91–96.
7. Hesdorffer DC, Shinnar S, Lewis DV. Design and phenomenology of the FEBSTAT study. Epilepsia 2012; 53(9): 1471–1480.
8. Isegawa Y, Mukai T, Nakano K. Comparison of the complete DNA sequences of human herpesvirus 6 variants A and B. J Virol: 1999; 73(10): 8053–8063.
9. Ablashi D, Agut H, Alvarez-Lafuente R. Classification of HHV-6A and HHV-6B as distinct viruses. Arch Virol 2014; 159(5): 863–870.
10. Morissette G, Flamand L., Herpesviruses and chromosomal integration. J Virol 2010; 84(23): 12100–12109.
11. Caselli E, Di Luca D., Molecular biology and clinical associations of Roseoloviruses human herpesvirus 6 and human herpesvirus 7. New Microbiol 2007; 30(3): 173–187.
12. Yoshikawa T., Human herpesvirus-6 and -7 infections in transplantation. Pediatr Transplant 2003; 7(1): 11–17.
13. Leibovitch EC, Jacobson S., Evidence linking HHV-6 with multiple sclerosis: an update. Curr Opin Virol 2014; 9: 127–133.
14. Ben-Fredj N, Ben-Selma W, Rotola A. Prevalence of human herpesvirus U94/REP antibodies and DNA in Tunisian multiple sclerosis patients. J Neurovirol 2013; 19(1): 42–47.
15. Behzad-Behbahani A, Mikaeili MH, Entezam M. Human herpesvirus-6 viral load and antibody titer in serum samples of patients with multiple sclerosis. J Microbiol Immunol Infect 2011; 44(4): 247–251.
16. Nora-Krukle Z, Chapenko S, Logina I. Human herpesvirus 6 and 7 reactivation and disease activity in multiple sclerosis. Medicina (Kaunas) 2011; 47(10): 527–531.
17. Horvat B, Berges BK, Lusso P., Recent developments in animal models for human herpesvirus 6A and 6B. Curr Opin Virol 2014; 9: 97–103.
18. Santoro F, Kennedy PE, Locatelli G. CD46 is a cellular receptor for human herpesvirus 6. Cell 1999; 99(7): 817–827.
19. t Hart BA, Massacesi L. Clinical, pathological, and immunologic aspects of the multiple sclerosis model in common marmosets (Callithrix jacchus). J Neuropathol Exp Neurol 2009; 68(4): 341–355.
20. Provost PJ, Keller PM, Banker FS. Successful infection of the common marmoset (Callithrix jacchus) with human varicella-zoster virus. J Virol 1987; 61(10): 2951–2955.
21. Chang H, Wachtman LM, Pearson CB. Non-human primate model of Kaposi’s sarcoma-associated herpesvirus infection. PloS Pathog 2009; 5(10). DOI: 10.1371/journal.ppat.1000606.
22. Omatsu T, Moi ML, Hirayama T. Common marmoset (Callithrix jacchus) as a primate model of dengue virus infection: development of high levels of viraemia and demonstration of protective immunity. J Gen Virol 2011; 92(Pt10): 2272–2280.
23. Sati P, Silva AC, van Gelderen P. In vivo quantification of T2 anisotropy in white matter fibers in marmoset monkeys. Neuroimage 2012; 59(2): 979–985.
24. Leibovitch E, Wohler JE, Macri CSM. Novel marmoset (Callithrix jacchus) model of human Herpesvirus 6A and 6B infections: immunologic, virologic and radiologic characterization. PloS Pathog 2013; 9(1): e1003138.
25. t Hart BA, van Meurs M, Brok HP. A new primate model for multiple sclerosis in the common marmoset. Immunol Today 2000; 21(6): 290–297.
26. Kap YS, Laman JD, t Hart BA., Experimental autoimmune encephalomyelitis in the common marmoset, a bridge between rodent EAE and multiple sclerosis for immunotherapy development. J Neuroimmune Pharmacol 2010; 5(2): 220–230.
27. Challoner PB, Smith KT, Parker JD. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Nati Acad Sci U S A 1995; 92(16): 7440–7444.
28. Goodman AD, Mock DJ, Powers JM. Human herpesvirus 6 genome and antigen in acute multiple sclerosis lesions. J Infect Dis 2003; 187(9): 1365–1376.
29. von Herrath MG, Fujinami RS, Whitton JL., Microorganisms and autoimmunity: making the barren field fertile? Nat Rev Microbiol 2003; 1(2): 151–157